Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEScreenNor: Aspirin Discontinuation at 24-28 Weeks in Preeclampsia Screening
NCT06108947Active, not recruiting
- Sponsor
- St. Olavs University Hospital
- Start
- Jan 2024
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of aspirin in preeclampsia (2 arms), sponsored by St. Olavs University Hospital. Primary endpoint: Number of patients with preterm preeclampsia. Started Jan 2024; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT06108947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06108947.